Immunotherapy failure in adrenocortical cancer: where next?
Immunotherapy is widely used in the treatment of different cancer types, including metastatic melanoma, non-small cell lung cancer, renal cell carcinoma and urothelial cancer. The results of the phase I JAVELIN study failed to demonstrate a substantial activity of the PDL-1 inhibitor Avelumab in adv...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2018-11-01
|
| Series: | Endocrine Connections |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0398.xml |